BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 12 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 12 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 12 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 13 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 13 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 14 hours ago Atmus Welcomes Heath Sharp to Board of Directors 16 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 16 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 12 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 12 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 12 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 13 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 13 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 14 hours ago Atmus Welcomes Heath Sharp to Board of Directors 16 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 16 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago
ADVERTISEMENT
Interviews

CERo Therapeutics CEO On Cancer Treatments

Chris Ehrlich, CEO of CERo Therapeutics, discusses the company’s novel approach to cancer immunotherapy and its CER-T platform. On Technology...

Interviews

Unicycive CEO On Kidney Care Focus

Dr. Shalabh Gupta, CEO of Unicycive Therapeutics, discusses the company’s focus on kidney care and its lead drug candidate for...